ID GNAS3_HUMAN Reviewed; 245 AA. AC O95467; B2RB88; E1P5G2; O95417; DT 17-OCT-2006, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-1999, sequence version 1. DT 13-FEB-2019, entry version 124. DE RecName: Full=Neuroendocrine secretory protein 55; DE Short=NESP55; DE Contains: DE RecName: Full=LHAL tetrapeptide; DE Contains: DE RecName: Full=GPIPIRRH peptide; DE Flags: Precursor; GN Name=GNAS {ECO:0000312|HGNC:HGNC:4392}; GN Synonyms=GNAS1 {ECO:0000312|EMBL:CAA08889.1}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] {ECO:0000312|EMBL:CAA08889.1} RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=9860993; DOI=10.1073/pnas.95.26.15475; RA Hayward B.E., Moran V., Strain L., Bonthron D.T.; RT "Bidirectional imprinting of a single gene: human GNAS1 encodes RT distinct maternally, paternally and biallelically derived proteins."; RL Proc. Natl. Acad. Sci. U.S.A. 95:15475-15480(1998). RN [2] {ECO:0000312|EMBL:CAB83214.1} RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=10749992; DOI=10.1093/hmg/9.5.835; RA Hayward B.E., Bonthron D.T.; RT "An imprinted antisense transcript at the human GNAS1 locus."; RL Hum. Mol. Genet. 9:835-841(2000). RN [3] {ECO:0000312|EMBL:AAF63226.1} RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=10729789; DOI=10.1159/000054535; RA Weiss U., Ischia R., Eder S., Lovisetti-Scamihorn P., Bauer R., RA Fischer-Colbrie R.; RT "Neuroendocrine secretory protein 55 (NESP55): alternative splicing RT onto transcripts of the GNAS gene and posttranslational processing of RT a maternally expressed protein."; RL Neuroendocrinology 71:177-186(2000). RN [4] {ECO:0000312|EMBL:AAD11804.1} RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Wang Y.Z., Kehlenbach R.H., Huttner W.B.; RT "Molecular characterization of XL2, a neuroendocrine-specific luminal RT Golgi-resident protein."; RL Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Tongue; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., RA Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., RA Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., RA Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., RA Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., RA Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., RA Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., RA Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., RA Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., RA Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., RA Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., RA Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., RA Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., RA Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., RA Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., RA Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., RA Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., RA Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., RA Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., RA Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [6] {ECO:0000312|EMBL:AAD11804.1} RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., RA Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., RA Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., RA Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R., RA Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., RA Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., RA Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., RA Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [7] RP INVOLVEMENT IN PHP1B. RX PubMed=11067869; DOI=10.1172/JCI10431; RA Liu J., Litman D., Rosenberg M.J., Yu S., Biesecker L.G., RA Weinstein L.S.; RT "A GNAS1 imprinting defect in pseudohypoparathyroidism type IB."; RL J. Clin. Invest. 106:1167-1174(2000). RN [8] RP INVOLVEMENT IN PHP1B. RX PubMed=11294659; DOI=10.1086/320117; RA Bastepe M., Lane A.H., Jueppner H.; RT "Paternal uniparental isodisomy of chromosome 20q -- and the resulting RT changes in GNAS1 methylation -- as a plausible cause of RT pseudohypoparathyroidism."; RL Am. J. Hum. Genet. 68:1283-1289(2001). RN [9] RP INVOLVEMENT IN PHP1B. RX PubMed=11029463; DOI=10.1074/jbc.M006032200; RA Wu W.-I., Schwindinger W.F., Aparicio L.F., Levine M.A.; RT "Selective resistance to parathyroid hormone caused by a novel RT uncoupling mutation in the carboxyl terminus of G alpha(s). A cause of RT pseudohypoparathyroidism type Ib."; RL J. Biol. Chem. 276:165-171(2001). RN [10] RP INVOLVEMENT IN PHP1B. RX PubMed=12858292; DOI=10.1086/377136; RA Jan de Beur S., Ding C., Germain-Lee E., Cho J., Maret A., RA Levine M.A.; RT "Discordance between genetic and epigenetic defects in RT pseudohypoparathyroidism type 1b revealed by inconsistent loss of RT maternal imprinting at GNAS1."; RL Am. J. Hum. Genet. 73:314-322(2003). RN [11] RP INVOLVEMENT IN AIMAH1. RX PubMed=12727968; DOI=10.1210/jc.2002-021362; RA Fragoso M.C.B.V., Domenice S., Latronico A.C., Martin R.M., RA Pereira M.A.A., Zerbini M.C.N., Lucon A.M., Mendonca B.B.; RT "Cushing's syndrome secondary to adrenocorticotropin-independent RT macronodular adrenocortical hyperplasia due to activating mutations of RT GNAS1 gene."; RL J. Clin. Endocrinol. Metab. 88:2147-2151(2003). RN [12] RP INVOLVEMENT IN PHP1B. RX PubMed=14561710; DOI=10.1172/JCI19159; RA Bastepe M., Froehlich L.F., Hendy G.N., Indridason O.S., Josse R.G., RA Koshiyama H., Koerkkoe J., Nakamoto J.M., Rosenbloom A.L., RA Slyper A.H., Sugimoto T., Tsatsoulis A., Crawford J.D., Jueppner H.; RT "Autosomal dominant pseudohypoparathyroidism type Ib is associated RT with a heterozygous microdeletion that likely disrupts a putative RT imprinting control element of GNAS."; RL J. Clin. Invest. 112:1255-1263(2003). RN [13] RP INVOLVEMENT IN PHP1B. RX PubMed=15800843; DOI=10.1086/429932; RA Linglart A., Gensure R.C., Olney R.C., Jueppner H., Bastepe M.; RT "A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism RT type Ib redefines the boundaries of a cis-acting imprinting control RT element of GNAS."; RL Am. J. Hum. Genet. 76:804-814(2005). RN [14] RP INVOLVEMENT IN PHP1B. RX PubMed=15592469; DOI=10.1038/ng1487; RA Bastepe M., Froehlich L.F., Linglart A., Abu-Zahra H.S., Tojo K., RA Ward L.M., Jueppner H.; RT "Deletion of the NESP55 differentially methylated region causes loss RT of maternal GNAS imprints and pseudohypoparathyroidism type Ib."; RL Nat. Genet. 37:25-27(2005). CC -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle CC {ECO:0000250}. Secreted {ECO:0000250}. Note=Neuroendocrine CC secretory granules. {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=8; CC Name=Nesp55 {ECO:0000269|PubMed:10729789, CC ECO:0000269|PubMed:10749992, ECO:0000269|PubMed:9860993, CC ECO:0000269|Ref.4}; CC IsoId=O95467-1; Sequence=Displayed; CC Note=Shares no sequence similarity with other isoforms due to a CC novel first exon containing the entire reading frame spliced to CC shared exon 2 so that exons 2-13 make up the 3'-UTR.; CC Name=XLas-1; CC IsoId=Q5JWF2-1; Sequence=External; CC Note=Gene prediction confirmed by EST data.; CC Name=XLas-2; CC IsoId=Q5JWF2-2; Sequence=External; CC Note=Gene prediction confirmed by EST data.; CC Name=XLas-3; CC IsoId=Q5JWF2-3; Sequence=External; CC Name=Gnas-1 {ECO:0000305}; Synonyms=Alpha-S2 {ECO:0000305}, GNASl CC {ECO:0000305}, Alpha-S-long {ECO:0000305}; CC IsoId=P63092-1, P04895-1; CC Sequence=External; CC Name=Gnas-2 {ECO:0000305}; Synonyms=Alpha-S1 {ECO:0000305}, GNASs CC {ECO:0000305}, Alpha-S-short {ECO:0000305}; CC IsoId=P63092-2, P04895-2; CC Sequence=External; CC Name=3; CC IsoId=P63092-3; Sequence=External; CC Note=No experimental confirmation available.; CC Name=4; CC IsoId=P63092-4; Sequence=External; CC Note=Gene prediction based on EST data.; CC -!- PTM: Binds keratan sulfate chains. {ECO:0000250|UniProtKB:O18979}. CC -!- PTM: May be proteolytically processed to give rise to a number of CC active peptides. {ECO:0000269|PubMed:10729789}. CC -!- DISEASE: ACTH-independent macronodular adrenal hyperplasia 1 CC (AIMAH1) [MIM:219080]: A rare adrenal defect characterized by CC multiple, bilateral, non-pigmented, benign, adrenocortical CC nodules. It results in excessive production of cortisol leading to CC ACTH-independent Cushing syndrome. Clinical manifestations of CC Cushing syndrome include facial and truncal obesity, abdominal CC striae, muscular weakness, osteoporosis, arterial hypertension, CC diabetes. {ECO:0000269|PubMed:12727968}. Note=The disease is CC caused by mutations affecting the gene represented in this entry. CC -!- DISEASE: Pseudohypoparathyroidism 1B (PHP1B) [MIM:603233]: A CC disorder characterized by end-organ resistance to parathyroid CC hormone, hypocalcemia and hyperphosphatemia. Patients affected CC with PHP1B lack developmental defects characteristic of Albright CC hereditary osteodystrophy, and typically show no other endocrine CC abnormalities besides resistance to PTH. CC {ECO:0000269|PubMed:11029463, ECO:0000269|PubMed:11067869, CC ECO:0000269|PubMed:11294659, ECO:0000269|PubMed:12858292, CC ECO:0000269|PubMed:14561710, ECO:0000269|PubMed:15592469, CC ECO:0000269|PubMed:15800843}. Note=The disease is caused by CC mutations affecting the gene represented in this entry. Most CC affected individuals have defects in methylation of the gene. In CC some cases microdeletions involving the STX16 appear to cause loss CC of methylation at exon A/B of GNAS, resulting in PHP1B. Paternal CC uniparental isodisomy have also been observed. CC -!- DISEASE: GNAS hyperfunction (GNASHYP) [MIM:139320]: This condition CC is characterized by increased trauma-related bleeding tendency, CC prolonged bleeding time, brachydactyly and mental retardation. CC Both the XLas isoforms and the ALEX protein are mutated which CC strongly reduces the interaction between them and this may allow CC unimpeded activation of the XLas isoforms. Note=The disease is CC caused by mutations affecting the gene represented in this entry. CC -!- MISCELLANEOUS: This protein is produced by a bicistronic gene CC which also produces the ALEX protein from an overlapping reading CC frame. {ECO:0000305}. CC -!- MISCELLANEOUS: The GNAS locus is imprinted in a complex manner, CC giving rise to distinct paternally, maternally and biallelically CC expressed proteins. The XLas isoforms are paternally derived, the CC Gnas isoforms are biallelically derived and the Nesp55 isoforms CC are maternally derived. CC -!- SIMILARITY: Belongs to the NESP55 family. {ECO:0000255}. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC ----------------------------------------------------------------------- DR EMBL; AJ009849; CAA08889.1; -; Genomic_DNA. DR EMBL; AJ251760; CAB83214.1; -; Genomic_DNA. DR EMBL; AF105253; AAF63226.1; -; mRNA. DR EMBL; AF107846; AAD11804.1; -; Genomic_DNA. DR EMBL; AK314549; BAG37135.1; -; mRNA. DR EMBL; CH471077; EAW75466.1; -; Genomic_DNA. DR EMBL; CH471077; EAW75457.1; -; Genomic_DNA. DR CCDS; CCDS13471.1; -. [O95467-1] DR RefSeq; NP_000507.1; NM_000516.5. DR RefSeq; NP_001070956.1; NM_001077488.3. DR RefSeq; NP_001070957.1; NM_001077489.3. DR RefSeq; NP_001296790.1; NM_001309861.1. DR RefSeq; NP_057676.1; NM_016592.3. [O95467-1] DR RefSeq; NP_536351.1; NM_080426.3. DR RefSeq; XP_016883310.1; XM_017027821.1. [O95467-1] DR RefSeq; XP_016883311.1; XM_017027822.1. [O95467-1] DR UniGene; Hs.125898; -. DR ProteinModelPortal; O95467; -. DR SMR; O95467; -. DR BioGrid; 109040; 104. DR iPTMnet; O95467; -. DR BioMuta; GNAS; -. DR EPD; O95467; -. DR PeptideAtlas; O95467; -. DR PRIDE; O95467; -. DR ProteomicsDB; 50901; -. DR DNASU; 2778; -. DR Ensembl; ENST00000313949; ENSP00000323571; ENSG00000087460. [O95467-1] DR Ensembl; ENST00000371075; ENSP00000360115; ENSG00000087460. [O95467-1] DR Ensembl; ENST00000371098; ENSP00000360139; ENSG00000087460. [O95467-1] DR GeneID; 2778; -. DR KEGG; hsa:2778; -. DR UCSC; uc002xzt.5; human. [O95467-1] DR CTD; 2778; -. DR DisGeNET; 2778; -. DR EuPathDB; HostDB:ENSG00000087460.23; -. DR GeneCards; GNAS; -. DR GeneReviews; GNAS; -. DR HGNC; HGNC:4392; GNAS. DR HPA; CAB010337; -. DR HPA; HPA018122; -. DR MalaCards; GNAS; -. DR MIM; 139320; gene+phenotype. DR MIM; 219080; phenotype. DR MIM; 603233; phenotype. DR neXtProt; NX_O95467; -. DR OpenTargets; ENSG00000087460; -. DR PharmGKB; PA175; -. DR GeneTree; ENSGT00940000156300; -. DR HOGENOM; HOG000276539; -. DR HOVERGEN; HBG081561; -. DR KO; K04632; -. DR OrthoDB; 754573at2759; -. DR ChiTaRS; GNAS; human. DR GeneWiki; GNAS_complex_locus; -. DR GenomeRNAi; 2778; -. DR Proteomes; UP000005640; Chromosome 20. DR Bgee; ENSG00000087460; Expressed in 252 organ(s), highest expression level in telencephalon. DR ExpressionAtlas; O95467; baseline and differential. DR Genevisible; O95467; HS. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB. DR GO; GO:0030133; C:transport vesicle; IEA:UniProtKB-SubCell. DR GO; GO:0007565; P:female pregnancy; NAS:UniProtKB. DR GO; GO:0040015; P:negative regulation of multicellular organism growth; ISS:UniProtKB. DR GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab. DR GO; GO:0009306; P:protein secretion; NAS:UniProtKB. DR GO; GO:0071107; P:response to parathyroid hormone; IMP:UniProtKB. DR InterPro; IPR009434; NESP55. DR Pfam; PF06390; NESP55; 1. PE 2: Evidence at transcript level; KW Alternative splicing; Cleavage on pair of basic residues; KW Complete proteome; Cushing syndrome; Cytoplasmic vesicle; KW Glycoprotein; Proteoglycan; Reference proteome; Secreted; Signal. FT SIGNAL 1 46 {ECO:0000250}. FT CHAIN 47 245 Neuroendocrine secretory protein 55. FT /FTId=PRO_0000253967. FT PEPTIDE 163 166 LHAL tetrapeptide. {ECO:0000255, FT ECO:0000303|PubMed:10729789}. FT /FTId=PRO_0000253968. FT PEPTIDE 238 245 GPIPIRRH peptide. {ECO:0000255, FT ECO:0000303|PubMed:10729789}. FT /FTId=PRO_0000253969. FT COMPBIAS 78 142 Glu-rich. {ECO:0000255}. FT CONFLICT 26 26 R -> C (in Ref. 4; AAD11804). FT {ECO:0000305}. FT CONFLICT 41 41 L -> D (in Ref. 4; AAD11804). FT {ECO:0000305}. FT CONFLICT 72 72 G -> GR (in Ref. 4; AAD11804). FT {ECO:0000305}. FT CONFLICT 133 133 P -> PETAP (in Ref. 4). {ECO:0000305}. FT CONFLICT 171 171 P -> A (in Ref. 4; AAD11804). FT {ECO:0000305}. FT CONFLICT 211 219 KEEKQRRRC -> REENSSDSS (in Ref. 4; FT AAD11804). {ECO:0000305}. FT CONFLICT 230 230 S -> F (in Ref. 4; AAD11804). FT {ECO:0000305}. SQ SEQUENCE 245 AA; 28029 MW; 4F02B8B1115089E2 CRC64; MDRRSRAQQW RRARHNYNDL CPPIGRRAAT ALLWLSCSIA LLRALATSNA RAQQRAAAQQ RRSFLNAHHR SGAQVFPESP ESESDHEHEE ADLELSLPEC LEYEEEFDYE TESETESEIE SETDFETEPE TAPTTEPETE PEDDRGPVVP KHSTFGQSLT QRLHALKLRS PDASPSRAPP STQEPQSPRE GEELKPEDKD PRDPEESKEP KEEKQRRRCK PKKPTRRDAS PESPSKKGPI PIRRH //